In the News
Novo expands pact with Flagship's Valo to include obesity, diabetes for $190M near-term
Exclusive: Flagship names two CEO-partners to lead Valo Health, Apriori Bio
It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?
Scenes from SLAS: AI, Organs-on-Chips Resonate at Record Lab Automation Show
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
Accessing artificial intelligence in pharmaceutical laboratories
Startup Showcase: Valo Health Revolutionizes Drug Discovery with Human-Centric Data and Machine Learning
The World's Top 100 Private Deep Tech Companies
Boston Business Journal unveils 2023 CFOs of the Year
Using Smart Tools for Smart Development
Partners Enter Multi-Programme Drug Discovery Agreement
Charles River Laboratories International, Inc. and Flagship’s Pioneering Medicines Enter Agreement Leveraging Ai-Powered Logica with Aim of Creating Novel Therapies for Unmet Medical Needs
Flagship company teams up with Charles River for AI drug discovery
Flagship's Pioneering Medicines to carve a new drug discovery path with Charles River's AI
Charles River and Flagship’s Pioneering Medicines to Leverage AI-Powered Logica to Create Novel Therapies for Unmet Medical Needs
Charles River and Flagship’s Pioneering Medicines Enter Agreement Leveraging AI-Powered Logica with Aim of Creating Novel Therapies for Unmet Medical Needs
BIO CEO 2023: Getting funded in a crowded environment, differentiation is key
Reimagining Drug Discovery: The Significance of AI
These Six Biotechs are Winning the Race to Get AI-Designed Drugs to the Clinic
BioSpace Clinical Catch-Up: Valo Health
2022 Best Tech Startups in Boston
Charles River, Valo Health create AI drug software
Previous
Next